
Sign up to save your podcasts
Or


Investors’ nerves were jangling as jewellery company Pandora warned that its sales and profit would be even lower than expected.
Quarterly results from pharma firm Eli Lilly and healthcare company CVS showed them in rude health.
See acast.com/privacy for privacy and opt-out information.
By FinimizeInvestors’ nerves were jangling as jewellery company Pandora warned that its sales and profit would be even lower than expected.
Quarterly results from pharma firm Eli Lilly and healthcare company CVS showed them in rude health.
See acast.com/privacy for privacy and opt-out information.